Ravi Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-01-2025
- Paid Up Capital ₹ 1.00 M
as on 03-01-2025
- Company Age 44 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.37 Cr
as on 03-01-2025
- Satisfied Charges ₹ 5.00 M
as on 03-01-2025
- Revenue 5.97%
(FY 2022)
- Profit 3.57%
(FY 2022)
- Ebitda -7.58%
(FY 2022)
- Net Worth 10.55%
(FY 2022)
- Total Assets 24.50%
(FY 2022)
About Ravi Pharmaceuticals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.37 Cr. The company has closed loans amounting to ₹5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Naynaben Patel, Vikrambhai Patel, Kamlesh Patel, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231GJ1980PTC003955
- Company No.
003955
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Sep 1980
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Anand, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ravi Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naynaben Patel  | Director | 03-Feb-1995 | Current |
| Vikrambhai Patel | Director | 23-Apr-2015 | Current |
| Kamlesh Patel | Director | 23-Apr-2015 | Current |
| Piyush Patel | Director | 03-Feb-1995 | Current |
Financial Performance of Ravi Pharmaceuticals.
Ravi Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced modest growth in revenue, with a 5.97% increase. The company also saw a slight improvement in profitability, with a 3.57% increase in profit. The company's net worth Soared by an impressive increase of 10.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ravi Pharmaceuticals?
Unlock access to Ravi Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Kalupur Commercial Co-Operative Bank Limited Creation Date: 06 Dec 2019 | ₹1.55 M | Open |
The Kalupur Commercial Co-Operative Bank Limited Creation Date: 29 Nov 2018 | ₹2.10 M | Open |
Others Creation Date: 24 Apr 2017 | ₹1.20 M | Open |
How Many Employees Work at Ravi Pharmaceuticals?
Ravi Pharmaceuticals has a workforce of 74 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ravi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ravi Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
